Abstract:Background: Maternally administered corticosteroids are routinely used to accelerate fetal lung maturation in pregnancies at risk of early preterm delivery. Although, among the subgroup with growth restriction, a majority show a temporary improvement in umbilical artery Doppler waveforms that may be sustained up to 7 days, a minority will acutely decompensate in response to corticosteroids in association with deteriorating umbilical and fetal Doppler waveforms. The basis for such acute Doppler changes is presently unknown. Our group has developed a noninvasive ultrasound methodology to measure wave reflections in the umbilical artery and have established that wave reflection metrics are sensitive to structural changes in the placental vasculature and to acute changes in vascular tone. Using this approach, we demonstrated in healthy pregnant mice that fetoplacental vascular resistance decreased in betamethasone-treated mice compared with saline-treated controls. Objective: This study aimed to investigate the effects of betamethasone administration on the wave reflection metrics in a mouse model of fetal growth restriction and to compare these findings with equivalent measurements in human fetuses. Study design: Pregnant CD-1 mice were housed from embryonic day 14.5 to embryonic day 17.5 in either a normoxic (21% O2, n=24) or hypoxic environment (11% O2, n=22), the latter being an established mouse model of fetal growth restriction. To investigate the effect of maternally administered betamethasone on the fetoplacental vasculature, ultrasound imaging was performed at baseline and 4 hours after treatment (either betamethasone or sterile saline). Umbilical artery wave reflection metrics were compared between the groups and for the effect of fetal sex. In addition, a cohort of 10 pregnant women with elevated umbilical artery pulsatility index and evidence of fetal growth restriction and 6 controls were imaged before and after corticosteroid administration. Results: In the mouse model, after betamethasone administration, the female fetuses from the hypoxia group showed a 15% increase in umbilical artery diameter, a 98% increase in umbilical artery blood flow, and a 27% decrease in umbilical artery reflection coefficient, whereas the males from the hypoxia group showed no substantial changes. In agreement with our mouse findings, umbilical artery reflections were found to be larger in human growth-restricted fetuses than controls in women at risk of preterm birth. Conclusion: Our studies provide insight into the mechanism whereby the human growth-restricted fetus may exhibit a temporary favorable fetoplacental vascular response to maternally administered corticosteroids. Further investigations are needed to understand why the male growth-restricted fetus seems unable to mount this favorable vascular response.

EP11.10: Impact of fetal lung maturation with ambroxol, betamethasone and its combination, its relationship with lamelar body count and neonatal complications

Hyperoxia-induced Changes in Estradiol Metabolism in Postnatal Airway Smooth Muscle

EP01.11: Application of fetal lung maturity grading model in predicting neonatal respiratory morbidity

EP06.73: Assessment of the severity of lung hypoplasia before fetoscopic endoluminal tracheal occlusion in fetuses affected by congenital diaphragmatic hernia using observed/expected total fetal lung volume

Case Study: Fetal Breathing Movements as a Proxy for Fetal Lung Maturity Estimation

EP10.21: Changes in lung size/volume and intrapulmonary Doppler velocimetry in fetuses with anhydramnios treated with serial amnioinfusions

Effects of antenatal application of ambroxol and glucocorticoid on lung morphometry and signal transduction of bone morphogenetic protein in the fetal rat.

Betamethasone improved near-term neonatal lamb lung maturation in experimental maternal asthma

EP06.25: Fetal ultrasound predictors for early postnatal intervention in congenital pulmonary airway malformations

Placental dysfunction and impaired fetal growth: a relationship with bronchopulmonary dysplasia and pulmonary hypertension

OP05.01: Impact of Doppler and gestational age on the prediction of adverse perinatal outcome in fetuses with late‐onset fetal growth restriction

OC02.04: *Association between adverse neonatal outcome and maternal hemodynamics and biomarkers in small for gestational age and fetal growth restriction

EP05.21: Postnatal outcome of fetal cortical malformations: systematic review of the literature

EP06.31: Prenatal approach to perinatal palliative care: a maternal‐fetal vision

EP06.34: O/E LHR at ultrasound versus observed‐to‐expected total fetal lung volume at MR imaging in the prediction of survival in fetuses with left‐sided congenital diaphragmatic hernia

Sex differences in modulation of fetoplacental vascular resistance in growth-restricted mouse fetuses following betamethasone administration: comparisons with human fetuses

EP11.01: Incidence and complications of obstructive sleep apnea in high‐risk pregnancies

Lung function response to postnatal corticosteroids for the prevention and treatment of bronchopulmonary dysplasia

OC16.07: Prediction of survival in congenital diaphragmatic hernia fetuses: which method is better using observed/expected total fetal lung volumes?

Early Arrest Of Lung Development And Its Impact On Childrens Airway Resistance

EP09.46: Biventricular remodelling in tetralogy of Fallot starts from fetal life